Tumor-myeloid crosstalk drives therapy resistance in localized bladder cancer
Filipe L.F. Carvalho, Ji‐Hyun Lee, Nikolaos Kalavros, Yuzhen Zhou, Daniel E. Michaud, Isabella Stelter, Hiba Siddiqui, Konrad Stawiski, Ramya Ravindranathan, Julia Perera, Shuoshuo Wang, Breanna M. Titchen, Amanda Garza, Kevin Bi, Jihye Park, , Eliezer M. Van Allen
This study identifies tumor-myeloid crosstalk as a driver of cisplatin resistance in bladder cancer and proposes PARP14 inhibition as a therapeutic strategy.
Cell Press Blue · Aug 20, 2026Peer-reviewedCancer Biology